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Background and purpose   Pain after total knee arthroplasty 
(TKA) is usually severe, and epidural analgesia or femoral nerve 
block has been considered to be an effective pain treatment. 
Recently, local infiltration analgesia (LIA) has become increas-
ingly popular but the outcome of this method regarding the anal-
gesic effect has not been fully evaluated. We compared local infil-
tration analgesia and femoral block with regard to analgesia and 
morphine demand during the first 24 h after TKA.
Methods   40 patients undergoing TKA under spinal anesthe-
sia were randomized to receive femoral nerve block (group F) or 
peri- and intraarticular infiltration analgesia (group LIA) with a 
mixture containing ropivacaine, ketorolac, and epinephrine. All 
patients had access to intravenous patient-controlled analgesia 
(PCA) with morphine postoperatively. Pain intensity at rest and 
upon movement was assessed on a numeric rating scale (0–10) on 
an hourly basis over 24 h if the patients were awake. 
Results   The average pain at rest was marginally lower with 
LIA (1.6) than with femoral block (2.2). Total morphine consump-
tion per kg was similar between the 2 groups. Ancillary analysis 
revealed that 1 of 20 patients in the LIA group reported a pain 
intensity of > 7 upon movement, as compared to 7 out of 19 in the 
femoral block group (p = 0.04). 
Interpretation   Both LIA and femoral block provide good anal-
gesia after TKA. LIA may be considered to be superior to femoral 
block since it is cheaper and easier to perform.
 
Pain after total knee arthroplasty (TKA) is usually severe and 
difficult to manage, and insufficient pain relief may delay 
recovery. The most effective pain treatment has traditionally 
been epidural analgesia or femoral nerve block (Singelyn et 
al. 1998, Ganapathy et al. 1999, Chelly et al. 2001, Davies et 
al. 2004, Ilfeld et al. 2006) in combination with opioid anal-
gesics and non-steroidal anti-inflammatory drugs (NSAIDs, 
cyclooxygenase (cox) inhibitors). Each of these methods has 
its specific side effects. Urinary retention and muscular weak-
ness are often reported after epidural analgesia. Unpleasant 
numbness of a large part of the lower extremity is common 
after femoral block. Opioid analgesics often cause sedation, 
nausea and vomiting, and also urinary retention. Non-selective 
cox inhibitors may cause gastrointestinal bleeding, renal com-
plications, and epidural hematoma, especially in combination 
with anti-thrombotic prophylaxis with low-molecular-weight 
heparin (Afzal et al. 2006). 
An alternative method for postoperative pain relief after 
TKA, which has attracted growing interest in recent years, is 
multimodal wound infiltration analgesic technique consisting 
of peri- and intraarticular infiltration of local anesthetics and 
NSAID in the knee (LIA) (Andersen et al. 2008a, b,  Kerr and 
Kohan 2008). This technique appears to offer several advan-
tages over traditional methods, since the analgesia affects 
only the surgical area with limited interference of the muscle 
strength. Thus, easier rehabilitation of the operated extremity 
and earlier discharge from the hospital can be expected (Reilly 
et al. 2005, Essving et al. 2009). Furthermore, recent studies 
have shown that the LIA technique reduces the requirement 
for postoperative analgesia with opioids (Tanaka et al. 2001, 
Busch et al. 2006, Vendittoli et al. 2006). 
Only a few investigators have randomly compared LIA with 
other methods with proven analgesic effect, such as femoral 
block or epidural analgesia (Parvataneni et al. 2007, Toftdahl 
et al 2007). Parvatanemi and collaborators (2007) have shown 
that a combination of a femoral block and local administra-
tion of bupivacaine, morphine, and epinephrine results in 
better pain relief and patient satisfaction than femoral block. 
Toftdahl and collaborators (2007) presented data suggesting 
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in faster postoperative activation, as indicated by being better 
able to walk more than 3 m on the first postoperative day 
as compared to femoral block. A retrospective comparison 
(DeWeese et al. 2001) indicated that epidural anesthesia with 
fentanyl and bupivacaine resulted in better pain relief and less 
use of other analgesics than did continuous infiltration of the 
knee with bupivacaine.
Femoral block is known to be an effective pain treatment 
after TKA (Szczukowski et al. 2004, Navas et al. 2005, Duarte 
et al. 2006). We compared the LIA technique with femoral 
block regarding efficacy of pain management at rest and upon 
movement after TKA. We also investigated whether LIA 
reduced the demand for intravenous morphine, administered 
via a patient-controlled analgesia (PCA) pump during the first 
24 h postoperatively. 
Patients 
This randomized parallel clinical 1:1 trial was used to com-
pare two protocols of postoperative pain relief after total knee 
arthroplasty. The inclusion criteria were as follows: patients 
with osteoarthritis or rheumatoid arthritis scheduled for pri-
mary unilateral elective total knee arthroplasty under spinal 
anesthesia, American Society of Anaesthesiologists (ASA) 
classification I–III, and more than 18 years old. Exclusion cri-
teria were allergy or intolerance to one of the study drugs, 
renal insufficiency, epilepsy, language difficulty, mental ill-
ness, dementia, QT interval on ECG > 450 msec before start. 
After giving oral and written informed consent, 40 patients 
scheduled for primary unilateral total knee arthroplasty were 
randomly assigned to 2 groups of postoperative pain manage-
ment immediately before the surgical procedure.
The setting of this single-site academic trial was the ortho-
pedics clinic at Karolinska University Hospital in Solna. The 
first patient was included on January 15, 2007 and the final 
patient was included on March 25, 2008. 
Randomization 
The randomization sequence was determined by mixing 40 
tickets, 20 labeled “F” and 20 labeled “LIA” in sealed opaque 
envelopes, and drawing one envelope at a time. The anesthesi-
ologist performing the spinal anesthesia and femoral block or 
supervising the LIA technique did not participate in the rand-
omization procedure. 
Interventions
Group F received a femoral block with ropivacaine (Narop; 
Astra Zeneca) and group LIA received peri- and intraarticular 
infiltration with ropivacaine + ketorolac (Toradol; Roche) and 
epinephrine (Adrenalin; NM Pharma).
Preparation
Before induction of spinal anesthesia, monitoring of oxygen 
saturation, blood pressure, and electrocardiogram (ECG) was 
started. Sedation was induced with midazolam (Midazolam; 
Alpharma), 1–2 mg intravenously. The level of spinal anes-
thesia was L2-L3 or L3-L4. Isobaric bupivacaine (Marcain 
Spinal; Astra Zeneca), 5 mg/mL at a volume of 3 mL, was 
injected with the patient lying with the operating side upwards. 
Before the start of the operation, all patients were sedated 
with midazolam or propofol (Propofol; Abbot), maintaining 
spontaneous ventilation. All patients received 2 g dicloxacil-
lin intravenously before surgery. Antithrombotic therapy with 
low-molecular-weight heparin (LMWH), enoxaparinnatrium 
(Klexane; Aventis Pharma) 40 mg, started the day before sur-
gery and was given for at least 5 days. The TKA procedure 
was performed following application of a thigh tourniquet, 
which was inflated just before skin incision and released after 
wound closure.
Group F
These patients received a femoral nerve block directly after 
spinal anesthesia. They were placed in the supine position. 
Under sterile conditions, the pulse of the femoral artery was 
identified, the needle (Plexolong Nanolin cannula facette 19G 
× 50 mm; Pajunk) connected to a nerve stimulator (Simplex B, 
serial no 17002; Braun) set up to deliver 1.2 mA was inserted 
cephalad, 45 degrees to skin and at the level of femoral crease, 
1–1.5 cm lateral to the femoral artery pulse (Winnie et al. 
1973). The femoral nerve was identified by eliciting quadri-
ceps muscle contractions (“dancing patella”). The current 
was gradually reduced to achieve twitches of the quadriceps 
muscle at 0.2–0.4 mA and the catheter (StimuLong Sono; 
Pajunk) was advanced through the needle.
The connection of the nerve stimulator was changed from 
needle to catheter, and stimulation intensity was started at 1.2 
mA until the desired motor response was obtained. There-
after, the intensity was reduced to 0.2–0.4 mA. The catheter 
was secured in place with transparent dressing. After negative 
blood aspiration, 30 mL ropivacaine (2 mg/mL) was injected 
followed by 15 mL of the same concentration every 4 hours 
for 24 h (total dose 240 mg/24 h). All patients had a urinary 
bladder catheter, inserted after spinal anesthesia and removed 
on the day after surgery. Group F received ketorolac (10 mg 
intravenously) in the post-anesthetic care unit, and again after 
8 h and 16 h. The total dose of ketorolac was 30 mg. 
Group LIA
These patients received peri- and intraarticular infiltration of 
a solution containing 150 mL ropivacaine (2 mg/mL), 1 ml 
ketorolac (30 mg/mL), and 5 ml epinephrine (0.1 mg/mL). 
This solution was prepared by the operation nurse before 
the start of the surgical procedure. The solution was given 
sequentially: 30 mL was injected intracutaneously at the start 
of the operation, 80 mL was injected into the posterior part of 
the capsule, close to the incision line, in the vastus interme-
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cementation, and 46 mL was instilled through an intraarticular 
catheter (epidural catheter gauge 16) inserted at the end of the 
surgical procedure. The total dose of ropivacaine during the 
first 24 h postoperatively was 300 mg and the total dose of 
ketorolac was 30 mg. 
Recovery
In the recovery room, all patients were provided with a patient-
controlled analgesia (PCA) morphine pump (Abott Pain Man-
ager; Abbot Laboratories) programmed to give an intravenous 
bolus of morphine (2 mg/dose) on demand with a lock-out 
time of 6 min and maximum dose of 35 mg over 4 h. All 
patients were introduced to the PCA technique and encour-
aged to use it as often as needed. After 24 hours, PCA pump 
use was verified with a printout of all doses of morphine and 
their time of administration. In addition to PCA, all patients 
received paracetamol (1 g × 4), either orally or intravenously. 
All patients were informed preoperatively by the nurse 
about pain assessment using a numeric rating scale (NRS): 0 = 
no pain and 10 = worst imaginable pain, based on the visual 
analog scale. NRS score at rest or upon movement during the 
first 24 h was recorded on an hourly basis by the patients, if 
awake.
ECG was performed preoperatively, 2 h after the end of 
surgery in the recovery room and 24 h postoperatively in 
the ward. All patients received postoperative physiotherapy, 
which started on the morning after operation. 
Statistics
Power analysis was performed using average VAS/NRS score 
during 24 h as the primary variable. A previous study of 
patients undergoing knee arthroplasty treated with a femoral 
nerve block reported a mean visual analog scale score of 3.6 
(SD 1.1) upon movement, at 24 h (Singelyn et al. 1998). We 
wanted to be able to detect a difference of 1 unit between LIA 
and femoral block. A sample size of 20 in each group would 
have 80% power to detect a difference between means of 1.0 
with a significance level (alpha) of 0.05 (two-tailed) using the 
unpaired Student’s t-test (GraphPad StatMate 1.0; GraphPad, 
San Diego, CA).
Outcomes 
Primary outcome. Differences in average pain intensity at rest 
and upon movement during the first 24 h after TKA were ana-
lyzed with the Mann-Whitney U-test. As we had 2 primary 
efficacy outcomes, a significance level of p < 0.02 was chosen 
for each analysis. No data were imputed for the primary out-
come if the patient was asleep or unable to record NRS. 
Secondary outcome. Total morphine use via the intravenous 
PCA pump during the 24-h period in the 2 study arms were 
analyzed with the Mann-Whitney U-test. Descriptive statistics 
were used to describe the morphine dose per kg in each study 
arm. 
Ancillary analyses
These were as follows. 1. Average pain intensity in 24 hours 
following imputation of missing data. Missing data was 
replaced by “0” if the patient was asleep. The most recent 
NRS score obtained was used to replace missing if pain rating 
was not provided due to other reasons. 2. The fraction of 
patients who reported a degree of pain intensity of < 5 at rest 
and during movement, i.e. mild pain intensity (Jensen et al. 
2003) in the 2 study groups was compared with Fisher’s exact 
test. 3. The fraction of patients who reported a pain intensity 
of > 7 at rest and during movement, i.e. severe pain (Jensen et 
al. 2003) in the two study groups was compared with Fisher’s 
exact test.
Safety monitoring
We monitored indications of cardiac arrhythmias and inci-
dence of reported adverse events.
Ethics
This trial (protocol no. 4773 KCR S2006-011) was conducted 
according to the Helsinki declaration and was approved by the 
regional ethics committee of the Karolinska Institute (EPN 
151:2006/34610) and the Swedish Medical Product Agency 
(EudraCT 2006-002581-19). The trial was monitored by the 
Karolinska Trial Alliance. This trial was not registered in the 
FDA database of clinical trials.
Results
40 patients participated in this trial, which was conducted. 
20 patients were randomized to LIA and 20 to femoral block. 
All patients completed the study. Data were analyzed accord-
ing to strict intention-to-treat (sITT) analysis according to 
Herman et al. (2009). One patient in the F group had a his-
tory of insensitivity to pain. He did not demand any morphine 
by PCA and pain was assessed as 0 on the NRS at all time 
points. The most recent NRS score obtained was used to 
replace missing if pain rating was not provided due to other 
reasons The most recent NRS score obtained was used to 
replace missing if pain rating was not provided due to other 
reasons and there was no use of morphine by PCA and 0 on 
the NRS at all times. This rare condition was not detected 
by the screening physician at inclusion in the trial. Exclusion 
of the data obtained from this patient and analysis accord-
ing to modified intention-to-treat method (mITT) (Herman et 
al. 2009) did not affect the outcome data (data not shown). 
The baseline characteristics and the demographic data of the 
patients were similar in both groups—except for the average 
weight, which was higher in the femoral block group (Table 
1). On average, 6 hourly time points of 24 were missing due 
to the patients being asleep or unable to fill in the CRF due to 
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Primary outcome
The average degree of pain intensity during the first postop-
erative day was low in both groups. The average degree of 
pain intensity at rest and upon movement was similar (Table 
2 and Figure 1).
Secondary outcomes
The average total morphine use via the intravenous PCA pump 
during the first postoperative day was 10 mg higher in the fem-
oral block group than in the LIA group, but this difference was 
not statistically significant (Figure 2). However, the morphine 
dose per kg was almost identical in both groups (Table 3). 
Ancillary analysis
1. Imputation of missing data by “0” if the patients was asleep, 
and using the most recent NRS score to replae missing data if 
pain rating was not provided due to other reasons resulted in a 
mean NRS at rest of 2.2 (95% CI: 1.4–3.1) in the femoral block 
group and of 1.5 (CI: 0.8–2.1) in the LIA group. The average 
pain score upon movement, following imputation of missing 
observations, was 2.2 (CI: 1.5–3.0) in the femoral block group 
and 2.1 (CI: 1.5–2.8) in the LIA group. 2. Incidence of NRS 
less than 5 throughout the 24-h observation period (probably 
acceptable pain relief) at rest and upon movement was twice 
as high in the LIA group than in the femoral block group 
(Table 4). 3. The incidence of NRS pain intensity greater than 
7 at rest on one or more occasions during the 24-h observation 
period was 5 times higher in the femoral block group than in 
the LIA group (Table 4). NRS greater than 7 upon movement 
was only reported by 1 of 20 patients in the LIA group and 7 
of 19 patients in the femoral block group (p = 0.04, Fisher’s 
exact test).
Safety analysis 
None of the patients had prolonged QT interval at the ECG 2 
hours and 24 hours postoperatively. No adverse events were 
reported during the 24-h study period. 
Table 1. Baseline patient demographics
    Femoral block  LIA
Sex (M/F)         8 / 12         11 / 9
Age, mean (range)        69 (53–88)        67 (29–85)
Weight in kg, mean (SD)   83 (13)  78 (18)
Length in cm, mean (SD)  168 (9)  171 (11)
BMI (mean)  27  27
ASA I / II / III  2 / 8 / 10  3 / 7 / 10
RA / OA  3 / 17  6 / 14
M: male; F: female; RA: rheumatoid arthritis; OA: osteoarthritis; 
ASA: American Society of Anaesthesiologists classification. 
Table 2. Primary outcome
  Femoral block   LIA
  n = 20  n = 20
Average pain NRS at rest a  2.1 (1.4–2.9)  1.6 (1.0–2.3) 
Average pain NRS upon movement a  2.4 (1.5–3.2)  2.4 (1.7–3.0)
a Reported data only. Missing NRS registrations due to the patients 
being asleep or unable to fill in the CRF due to other activities were 
not imputed. Data are expressed as mean (95% CI). 
Figure 1. Average pain score (NRS) at rest and upon movement over 24 h after surgery. If the 
patient was sleeping, no data were recorded (n = 20 in each group). 
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Figure 2. Average morphine use (PCA) in 
mg for the 2 groups during the first 24 h 
after surgery (n = 20 in each group). 










Table 3. Secondary outcome
  Femoral block  LIA
Total morphine (mg)   32 (23–41)  24 (16–31)
Total morphine (mg/kg)   0.4 (0.3–0.5)  0.3 (0.2–0.4)
Total morphine refers to intravenous morphine administered via a 
PCA in 24 h. Data are expressed as mean (95% CI).Acta Orthopaedica 2011; 82 (3): 441–447  445
Discussion 
Our data indicate that the 2 analgesic regimens gave similar 
quality of pain relief during the first 24 h. Some studies have 
compared LIA with other pain treatments after TKA, such 
as systemic analgesia and placebo, and have reported supe-
rior outcome with LIA regarding postoperative analgesia and 
opioid consumption. The positive results in those studies are 
not surprising, since the analgesic treatment in the control 
groups mainly consisted of less effective methods of post-
operative pain treatment (Lombardi et al. 2004, Vendittoli et 
al. 2006, Parvataneni et al. 2007, Rostlund and Kehlet 2007, 
Andersen et al. 2008, Kerr and Kohan 2008, Essving et al. 
2009).
Both femoral block and LIA resulted in low average pain 
intensity during the first postoperative day. The average degree 
of pain intensity at rest, but not upon movement, was slightly 
lower in the LIA group. This small difference is probably 
without clinical significance. The access to PCA-administered 
morphine until pain was acceptably low, NRS < 4, would be 
expected to result in a similar degree of pain relief. The total 
use of morphine per kg was similar in both groups, which 
indicates that the pain relief of both methods was compara-
ble. Using ancillary analysis, we found that a pain intensity 
of greater than 7 on NRS with movement was less common 
in the LIA group, a difference that reached statistical signifi-
cance. This result must be regarded as hypothesis generating, 
and should be confirmed by a separate study. 
We compared 2 routinely used methods that are both effec-
tive for postoperative pain relief in TKA. None of the patients 
in this study were given an analgesic other than intravenous 
morphine, administered through a PCA pump, and paraceta-
mol (4 g in 24 h).
Femoral block and LIA after TKA have been compared pre-
viously (Parvataneni et al. 2007, Toftdahl et al. 2007). How-
ever, in the study by Toftdahl et al., the femoral block group 
also received intraarticular injection of morphine (4 mg) and 
bupivacain (50 mg), and in the study by Parvateneni et al. a 
variable dose of morphine (4–10 mg) and methylprednisolone 
(40 mg) was given to the LIA group. In both trials, reduced 
opioid consumption was found with LIA. Pain relief at rest 
was good, but was similar in the 2 groups during the first 24 h. 
In accordance with our findings (with fewer patients reporting 
high-intensity pain on movement in the LIA group), a previ-
ous study has found better pain relief during physiotherapy 
after LIA (Toftdahl et al. 2007). 
The tendency of lower efficacy with femoral block may be 
due to the fact that the posterior part of the knee is innervated 
by the sciatic nerve. Thus, a femoral block does not cover 
this area and supplementary treatment with systemic analge-
sics such as opioids and NSAIDs is needed. In our study, all 
the patients in the femoral group received ketorolac in a total 
dose of 30 mg intravenously during the first 24 h—the same 
amount as administered locally in the LIA group. 
One explanation as to why LIA is so effective might be that 
there is evidence for a clinically relevant peripheral analgesic 
action of intraarticular NSAIDs (Romsing et al. 2000). The 
analgesic effect of NSAIDs may be better after intraarticular 
administration than after systemic administration (Day et al. 
1999). Furthermore, in a study comparing the analgesic effect 
of NSAIDs after wound infiltration with that after systemic 
administration, the result was in favor of local infiltration 
(Ben-David et al. 1995). Our study groups received NSAID 
either intravenously (group F) or via peri- and intraarticular 
infiltration (group LIA), but the study design was not set up to 
answer the question of the most effective route of administra-
tion of NSAID. Furthermore, a clear relationship between the 
dose of NSAIDs and their analgesic effect has been established 
(Collins et al. 1998). Thus, the systemic dose of NSAIDs used 
may have been too low for full analgesic effect in the femoral 
group.
The high quality of the femoral blocks in this study might be 
one explanation for the small difference in analgesic efficacy 
between the two methods. It is well known that the quality of 
a peripheral blockade might depend on the experience of the 
anesthesiologist, and all but 2 blocks were performed by an 
experienced anaesthesiologist (FA). 
Experience is also of importance for perioperative local 
infiltration. When we introduced the LIA method at our insti-
tution, we noticed that surgeons also have a learning curve 
in doing effective local infiltration. The more experienced the 
surgeon is, the more effective is the postoperative pain relief. 
This may also be due to less tissue trauma being produced by 
experienced surgeons.
Limitations of the study
Open labeled studies have a disadvantage compared to blinded 
studies, due the interference of expectancy of the patient and 
the staff in interpretation of the outcome. The patients in group 
F received an initial femoral nerve block followed by bolus 
doses of ropivacaine every 4 h during the first 24 h, and not 
continuous infusion of local anesthetic, which might have been 
more effective due to a steady concentration of ropivacaine 
over time and probably better pain control. The randomization 
procedure was simple and did not use block design, which 
Table 4. Ancillary analysis 
  Femoral block (n = 19)  LIA (n = 20)
NRS < 5 at rest  7  12 
NRS < 5 upon movement  5     8 
NRS > 7 at rest  5    1 
NRS > 7 upon movement   7     1 a     
NRS < 5 refers to the number of patients who reported a NRS lower 
than 5 throughout the 24 h of observation. NRS > 7 refers to the 
number of patients who reported pain intensity greater than 7 once 
or more often during the 24 h of observation.
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could be a disadvantage. Furthermore, stratification according 
to to sex and osteoarthritis or rheumatoid arthritis might have 
resulted in 2 groups with less difference.
Since the number of patients with rheumatoid arthritis was 
higher in the LIA group, we cannot rule out that LIA or femo-
ral block may be more effective in this patient category. The 
observation period of 24 h may be too short, especially with 
regard to adverse events. Furthermore, it would have been 
good to investigate whether there were differences regarding 
ease of rehabilitation or physical therapy.
 In summary, in this randomized study we could not confirm 
that there was any clear superiority of perioperative infiltra-
tion of local anaesthetic (LIA) over femoral block in combi-
nation with i.v. ketorolac in total knee arthroplasty, since the 
two analgesic regimens gave similar quality of pain treatment 
during the first 24 h. However, LIA may be considered the 
preferred option since it is cheaper and easier to perform than 
femoral block. In addition, LIA involves the surgeon in allevi-
ating postoperative pain.
FA: Conducted the femoral block and supervised the LIA procedure and par-
ticipated in the trial application. EBN: Participated in the planning of the trial 
and acted as anaesthesiologist of some of the patients in this trial. COS: Par-
ticipated in the planning and supervising of the trial and finalizing the manu-
script. PW: Performed most of the TKA in this trial. Participated in organizing 
the trial. CO: Responsible for the planning and application of the trial to the 
medical product agency. Participated in writing the manuscript. 
The present study was supported by the Karolinska Institute Foundations and 
the Swedish Medical Research Council. We thank anesthesia nurse Anna-
Lena Törnqvist for her skill in giving instructions to the patients about the 
PCA pump.
No competing interests declared. 
Afzal A, Hawkins F, Rosenquist R W. Epidural hematoma in a patient receiv-
ing epidural analgesia and LMWH after total-knee arthroplasty. Reg 
Anesth Pain Med 2006; 31 (5): 480.
Andersen L O, Husted H, Otte K S, Kristensen B B, Kehlet H. High-volume 
infiltration analgesia in total knee arthroplasty: a randomized, double-blind, 
placebo-controlled trial. Acta Anaesthesiol Scand 2008a; 52 (10): 1331-5.
Andersen L O, Husted H, Otte K S, Kristensen B B, Kehlet H. A compression 
bandage improves local infiltration analgesia in total knee arthroplasty. 
Acta Orthop 2008b; 79 (6): 806-11.
Ben-David B, Katz E, Gaitini L, Goldik Z. Comparison of i.m. and local infil-
tration of ketorolac with and without local anaesthetic. Br J Anaesth 1995; 
75 (4): 409-12.
Busch C A, Shore B J, Bhandari R, Ganapathy S, MacDonald S J, Bourne R 
B, et al. Efficacy of periarticular multimodal drug injection in total knee 
arthroplasty. A randomized trial. J Bone Joint Surg (Am) 2006; 88 (5): 
959-63.
Chelly J E, Greger J, Gebhard R, Coupe K, Clyburn T A, Buckle R, et al. Con-
tinuous femoral blocks improve recovery and outcome of patients undergo-
ing total knee arthroplasty. J Arthroplasty 2001; 16 (4): 436-45.
Collins S L, Moore R A, McQuay H J, Wiffen P J. Oral ibuprofen and diclof-
enac in post-operative pain: a quantitative systematic review. Eur J Pain 
1998; 2 (4): 285-91.
Davies A F, Segar E P, Murdoch J, Wright D E, Wilson I H. Epidural infusion 
or combined femoral and sciatic nerve blocks as perioperative analgesia for 
knee arthroplasty. Br J Anaesth 2004; 93 (3): 368-74.
Day R O, McLachlan A J, Graham G G, Williams K M. Pharmacokinetics of 
nonsteroidal anti-inflammatory drugs in synovial fluid. Clin Pharmacokinet 
1999; 36 (3): 191-210.
DeWeese F T, Akbari Z, Carline E. Pain control after knee arthroplasty: 
intraarticular versus epidural anesthesia. Clin Orthop 2001; (392): 226-31.
Duarte V M, Fallis W M, Slonowsky D, Kwarteng K, Yeung C K. Effective-
ness of femoral nerve blockade for pain control after total knee arthroplasty. 
J Perianesth Nurs 2006; 21 (5): 311-6.
Essving P, Axelsson K, Kjellberg J, Wallgren O, Gupta A, Lundin A. Reduced 
hospital stay, morphine consumption, and pain intensity with local infil-
tration analgesia after unicompartmental knee arthroplasty. Acta Orthop 
2009; 80 (2): 213-9.
Ganapathy S, Wasserman R A, Watson J T, Bennett J, Armstrong K P, Stockall 
C A, et al. Modified continuous femoral three-in-one block for postopera-
tive pain after total knee arthroplasty. Anesth Analg 1999; 89 (5): 1197-
202.
Herman A, Botser I B, Tenenbaum S, Chechick A. Intention-to-treat analysis 
and accounting for missing data in orthopaedic randomized clinical trials. J 
Bone Joint Surg (Am) 2009; 91 (9): 2137-43.
Ilfeld B M, Gearen P F, Enneking F K, Berry L F, Spadoni E H, George S Z, et 
al. Total knee arthroplasty as an overnight-stay procedure using continuous 
femoral nerve blocks at home: a prospective feasibility study. Anesth Analg 
2006; 102 (1): 87-90.
Jensen M P, Chen C, Brugger A M. Interpretation of visual analog scale rat-
ings and change scores: a reanalysis of two clinical trials of postoperative 
pain. J Pain 2003; 4 (7): 407-14.
Kerr D R, Kohan L. Local infiltration analgesia: a technique for the control 
of acute postoperative pain following knee and hip surgery: a case study of 
325 patients. Acta Orthop 2008; 79 (2): 174-83.
Lombardi A V, Jr., Berend K R, Mallory T H, Dodds K L, Adams J B. Soft 
tissue and intra-articular injection of bupivacaine, epinephrine, and mor-
phine has a beneficial effect after total knee arthroplasty. Clin Orthop 2004; 
(428): 125-30.
Navas A M, Gutierrez T V, Moreno M E. Continuous peripheral nerve block-
ade in lower extremity surgery. Acta Anaesthesiol Scand 2005; 49 (8): 
1048-55.
Parvataneni H K, Shah V P, Howard H, Cole N, Ranawat A S, Ranawat C S. 
Controlling pain after total hip and knee arthroplasty using a multimodal 
protocol with local periarticular injections: a prospective randomized 
study. J Arthroplasty (Suppl 2) 2007; 22 (6): 33-8.
Reilly K A, Beard D J, Barker K L, Dodd C A, Price A J, Murray D W. Effi-
cacy of an accelerated recovery protocol for Oxford unicompartmental 
knee arthroplasty–a randomised controlled trial. Knee 2005; 12 (5): 351-7.
Romsing J, Moiniche S, Ostergaard D, Dahl J B. Local infiltration with 
NSAIDs for postoperative analgesia: evidence for a peripheral analgesic 
action. Acta Anaesthesiol Scand 2000; 44 (6): 672-83.
Rostlund T, Kehlet H. High-dose local infiltration analgesia after hip and knee 
replacement–what is it, why does it work, and what are the future chal-
lenges? Acta Orthop 2007; 78 (2): 159-61.
Singelyn F J, Deyaert M, Joris D, Pendeville E, Gouverneur J M. Effects of 
intravenous patient-controlled analgesia with morphine, continuous epidu-
ral analgesia, and continuous three-in-one block on postoperative pain and 
knee rehabilitation after unilateral total knee arthroplasty. Anesth Analg 
1998; 87 (1): 88-92.
Szczukowski M J, Jr., Hines J A, Snell J A, Sisca T S. Femoral nerve block for 
total knee arthroplasty patients: a method to control postoperative pain. J 
Arthroplasty 2004; 19 (6): 720-5.Acta Orthopaedica 2011; 82 (3): 441–447  447
Tanaka N, Sakahashi H, Sato E, Hirose K, Ishii S. The efficacy of intra-
articular analgesia after total knee arthroplasty in patients with rheumatoid 
arthritis and in patients with osteoarthritis. J Arthroplasty 2001; 16 (3): 
306-11.
Toftdahl K, Nikolajsen L, Haraldsted V, Madsen F, Tonnesen E K, Soballe K. 
Comparison of peri- and intraarticular analgesia with femoral nerve block 
after total knee arthroplasty: a randomized clinical trial. Acta Orthop 2007; 
78 (2): 172-9.
Vendittoli P A, Makinen P, Drolet P, Lavigne M, Fallaha M, Guertin M C, et 
al. A multimodal analgesia protocol for total knee arthroplasty. A random-
ized, controlled study. J Bone Joint Surg (Am) 2006; 88 (2): 282-9.
Winnie A P, Ramamurthy S, Durrani Z. The inguinal paravascular technic of 
lumbar plexus anesthesia: the “3-in-1 block”. Anesth Analg 1973; 52 (6): 
989-96.